Home / Business and Economy / Artrya Lands Biggest Customer, Stock Dips
Artrya Lands Biggest Customer, Stock Dips
27 Oct
Summary
- Artrya secured its largest customer to date with Huntsville Hospital.
- Scan-volume outlook increased to 22,000-23,000 for the new fiscal year.
- Stock experienced a 4.49% decline to $2.34 following the update.
Artrya has secured its largest customer to date, signing a 5-year commercial agreement with Huntsville Hospital Health System. This significant milestone was announced alongside an upward revision of the company's CCTA scan exit run-rate outlook to between 22,000 and 23,000 for the new financial year, a notable increase from the previous 15,000 target.
Despite these positive developments, Artrya's stock experienced a decline of 4.49%, trading at $2.34. The company reported AUD 84,000 in customer receipts for the September quarter, with operating cash outflows rising to AUD 7.3 million. Cash reserves stood at AUD 67.2 million at the quarter's end, with an anticipated AUD 4.8 million R&D tax rebate due in early 2027.
The company is focusing on accelerating customer go-lives, expanding usage within existing systems, and converting more partners into paying customers. Delays in the Salix Coronary Flow submission, attributed to inconsistencies in a clinical substudy, have added a layer of caution, though the company emphasizes that core platform modules are already cleared and in use.
